The Results of Prof Juliet Gray’s Research Into Antibody Immunotherapy for Children with Neuroblastoma. Prof Juliet Gray (L) and Dr Tia Kulanthaivadivel (R) In 2019, Neuroblastoma UK joined forces with childhood cancer charities The Bradley Lowery Foundation and Niamh's Next Step to support more vital research into neuroblastoma. Together, the three charities funded essential work into antibody immunotherapy for children with neuroblastoma, a form of treatment which relies on cells of the body’s own immune system to kill cancer cells. This was led by Prof Juliet Gray, with Prof Stephen Beers ..read more

A big thank you to Aurora, one of the UK’s fastest-growing Print Management, Office Supplies and Telecoms Providers, for choosing Neuroblastoma UK as one of its charity partners for this year. Aurora employees will be fundraising throughout the year at a range of events, including a raffle at their forthcoming April conference, a cake sale, a day at the races and a Christmas charity quiz. Last year’s charities received over £6K each and Aurora are hoping to top that this year. Aurora employees will be fundraising throughout the year at a range of events, including a raffle at their forthcoming ..read more

View fullsize View fullsize View fullsize It was sold out two months in advance, so it was no surprise to see a packed auditorium at Selwyn College Cambridge for the 6th Neuroblastoma UK Research Symposium on 21st and 22nd March 2024. Over 130 scientists and clinicians attended from across Europe, US, and further afield, including world leading experts in pre-clinical and clinical neuroblastoma research. The event was organised by Neuroblastoma UK together with the CRUK Cambridge Centre Paediatric Cancer Programme, with particular thanks to Dr Guy Blanchard, Prof Anna Philpott and Prof Suza ..read more

“Big things often have small beginnings,” said Benjamin Franklin and this looks to be the case with Dr Jinhui Gao’s small grant award of £5,000 investigating the benefit of combining EZH2 inhibitors and anti-GD2 immunotherapy. In 2023, Dr Gao, working with Prof Juliet Gray and Dr Zoë Walters at the University of Southampton, aimed to determine the role of natural killer cell- mediated anti-tumour effects in neuroblastoma, after treatment with EZH2. The objectives of the study were to look at the correlation between EZH2 protein expression and the surface expression of natural killer ligands ..read more

As we draw closer to the end of a busy but exciting year, all of us at Neuroblastoma UK would like to thank you for your support in the fight against childhood cancer. We rely on the generosity of our supporters and partners to accelerate vital research into neuroblastoma. 2023 has been a challenging year with rising inflation and the cost of living, so we truly appreciate your help. Because of you, we plan to launch a new Research Grant Round in 2024 to help take forward even more research. Thank you. Our highlights from 2023 Funding research Thanks to your generous donations, 10 research ..read more

As we draw closer to the end of a busy but exciting year, all of us at Neuroblastoma UK would like to thank you for your support in the fight against childhood cancer. Our highlights from 2023 Funding research Thanks to your generous donations, 10 research projects into neuroblastoma progressed in 2023, involving labs in the UK, France and Netherlands including: Dr Jinhui Gao’s work to potentially improve immunotherapy Dr Rob Ewing is looking at the appropriateness of using the Zika virus to potentially kill neuroblastoma cells Professor Louis Chesler is working to develop blood-base ..read more

For families whose lives have been turned upside down by neuroblastoma, Christmas can be a difficult time of the year. Their child may be having cancer treatment, is too ill to enjoy the festivities or devastatingly, has sadly passed away. With our new Gift Donations, you can help to support vital research to develop new, more effective and less punishing treatment for children with neuroblastoma - and help save more young lives. So if you’re looking for a last minute Christmas gift, want to give a gift with a difference or give a virtual gift to a loved one, our new charity Gift Donations cou ..read more

For the first time, Neuroblastoma UK took part in the Big Give Christmas Challenge 2023, the UK’s largest matched funding campaign, between 12pm on 28th November and 12pm on 5th December 2023. Our aim was to raise £8,000 - and we did it! Thanks to pledges of £4,000 from The Hospital Saturday Fund and generous donors, your donations were matched. We raised a grand total to £8,602 in just seven days. Amazingly, we hit our target of £8,000 with two days to go. We were blown away by everyone’s support, thank you. The money raised from the Big Give Christmas Challenge will enable scientists to take ..read more

Press release: 23 November 2023 Childhood cancer survivor from Bristol fronts Christmas fundraising campaign Six year old Apollinia celebrates one year in remission as she fronts Neuroblastoma UK’s campaign to raise £8,000 for neuroblastoma research Apple (full name Apollonia), was diagnosed with stage four, high risk neuroblastoma, an aggressive childhood cancer in 2021. This November, Apple celebrates one year in remission as she fronts Neuroblastoma UK’s first matched-funding campaign with the Big Give Christmas Challenge. Apple stars alongside the charity’s celebrity Patrons Alan Carr and ..read more

Press release: 15 November Celebrity Patrons of children’s charity Neuroblastoma UK call on the public to help raise £8,000 and accelerate research into neuroblastoma, a rare childhood cancer.  For the first time, Neuroblastoma UK is participating in the Big Give Christmas Challenge 2023, the UK’s largest matched funding campaign. The charity aims to raise £4,000 from online donations with a further £4,000 available thanks to support from The Hospital Saturday Fund and pledges from generous donors. Between 12pm on 28th November and 12pm on 5th December 2023, donations made to the charity ..read more